DICE Therapeutics Inc. (DICE)
NASDAQ: DICE
· Real-Time Price · USD
47.55
0.03 (0.06%)
At close: Aug 08, 2023, 10:00 PM
DICE Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -34.82M | -25.65M | -23.22M | -20.55M | -21.52M | -18.59M | -16.2M | -17.34M | -7.36M | -8.07M |
Depreciation & Amortization | 687K | 630K | 609K | 595K | 700K | 519K | 156K | 146K | 179K | 180K |
Stock-Based Compensation | 5.5M | 4.89M | 3.34M | 3.46M | 4.21M | 1.81M | 1.68M | 3.16M | 396K | 347K |
Other Working Capital | 2.87M | -472K | -529K | 142K | 1.51M | -1.31M | 1.92M | 1.65M | -991K | -157K |
Other Non-Cash Items | -2.7M | -2.37M | 288K | 98K | 930K | 29K | 164K | 1.4M | 219K | -8K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | 329K | 135K | 1.38M | n/a | n/a |
Change in Working Capital | 2.75M | 60K | 1.09M | 1.07M | -1.26M | 1.74M | -217K | 3.7M | -1.39M | -451K |
Operating Cash Flow | -28.58M | -22.44M | -17.89M | -15.32M | -16.94M | -14.16M | -14.41M | -8.92M | -7.96M | -8M |
Capital Expenditures | -1.83M | -202K | -437K | -524K | -891K | -385K | -196K | -121K | -36K | -365K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -53.96M | -397.72M | -44.61M | -29.14M | -44.61M | -65.51M | -191.5M | -15K | -2.87M | -24.08M |
Sales Maturities Of Investments | 55M | 60.27M | 106.42M | 76.5M | 28.06M | 18M | 11.87M | 2.7M | n/a | n/a |
Other Investing Acitivies | n/a | n/a | 44.61M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -792K | -337.65M | 105.98M | 46.84M | -17.44M | -47.89M | -179.83M | 2.56M | -2.91M | -24.45M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | 4.83B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -4.83B | 292K | 325.04M | -8K | -2.67M | -108K | -1.54M | 302.46M | 1.85M | -2.52M |
Financial Cash Flow | 1.24M | 292K | 325.04M | -8K | -2.67M | -108K | -1.54M | 302.46M | 1.85M | -2.52M |
Net Cash Flow | -28.13M | -359.8M | 413.12M | 31.5M | -37.05M | -62.16M | -195.78M | 296.11M | -9.02M | -34.97M |
Free Cash Flow | -30.41M | -22.64M | -18.33M | -15.85M | -17.83M | -14.55M | -14.61M | -9.04M | -7.99M | -8.36M |